DJO Finance LLC:企業の戦略的SWOT分析

◆英語タイトル:DJO Finance LLC - Strategic SWOT Analysis Review
◆商品コード:DATA904C4787
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

DJO Finance LLC – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

DJO Finance LLC (DJOFL), a wholly owned indirect subsidiary of DJO Global Inc, is a medical device company. It undertakes the manufacturing, development, and distribution of musculoskeletal health, vascular health and pain management products to address the complete spectrum of preventative, pre-operative, post-operative, clinical and home rehabilitation care. The company offers its products to orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers and other healthcare professionals. DJO operates in France, Germany, Italy, Australia, Belgium, Canada, Sweden, South Africa, Spain, Switzerland, the US and the UK. DJO is headquartered in Vista, California, the US.

DJO Finance LLC Key Recent Developments

Aug 06,2018: DJO Global announces financial results for second quarter 2018

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
Section 1 – About the Company 6
DJO Finance LLC – Key Facts 6
DJO Finance LLC – Key Employees 7
DJO Finance LLC – Key Employee Biographies 8
DJO Finance LLC – Major Products and Services 9
DJO Finance LLC – History 12
DJO Finance LLC – Company Statement 15
DJO Finance LLC – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 18
Company Overview 18
DJO Finance LLC – Business Description 19
Business Segment: Bracing and Vascular 19
Overview 19
Performance 19
Business Segment: International 19
Overview 19
Performance 19
Business Segment: Recovery Sciences 20
Overview 20
Performance 20
Business Segment: Surgical Implant 20
Overview 20
Performance 20
Geographical Segment: Australia and Asia Pacific 20
Performance 20
Geographical Segment: Canada 21
Performance 21
Geographical Segment: Germany 21
Performance 21
Geographical Segment: Latin America 21
Performance 21
Geographical Segment: Other Europe, Middle East, and Africa 21
Performance 21
Geographical Segment: The US 21
Performance 21
R&D Overview 21
DJO Finance LLC – SWOT Analysis 22
SWOT Analysis – Overview 22
DJO Finance LLC – Strengths 22
DJO Finance LLC – Weaknesses 23
DJO Finance LLC – Opportunities 24
DJO Finance LLC – Threats 25
DJO Finance LLC – Key Competitors 26
Section 3 – Company’s Recent Developments 27
Aug 06, 2018: DJO Global announces financial results for second quarter 2018 27
Section 4 – Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
DJO Finance LLC, Key Facts 6
DJO Finance LLC, Key Employees 7
DJO Finance LLC, Key Employee Biographies 8
DJO Finance LLC, Major Products and Services 9
DJO Finance LLC, History 12
DJO Finance LLC, Other Locations 16
DJO Finance LLC, Subsidiaries 16
DJO Finance LLC, Key Competitors 26

★海外企業調査レポート[DJO Finance LLC:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Collegium Pharmaceutical Inc (COLL)-医療機器分野:企業M&A・提携分析
    Summary Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-te …
  • Elos Medtech AB (ELOS B):企業の財務・戦略的SWOT分析
    Elos Medtech AB (ELOS B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Canadian Pacific Railway Limited (CP):企業の財務・戦略的SWOT分析
    Canadian Pacific Railway Limited (CP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Societe Des Bains De Mer Sa
    Societe Des Bains De Mer Sa - Strategy, SWOT and Corporate Finance Report Summary Societe Des Bains De Mer Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Contact Energy Limited:企業の戦略・SWOT・財務情報
    Contact Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Contact Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hachsharat Hayishuv Hotels Ltd.:企業の戦略・SWOT・財務分析
    Hachsharat Hayishuv Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hachsharat Hayishuv Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • GEDI Gruppo Editoriale SpA (GEDI):企業の財務・戦略的SWOT分析
    GEDI Gruppo Editoriale SpA (GEDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Li Ning Company Ltd (2331)
    Li Ning Company Ltd (2331) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Warner Music Group Corp:企業の戦略的SWOT分析
    Warner Music Group Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Purepoint Uranium Group Inc (PTU):企業の財務・戦略的SWOT分析
    Purepoint Uranium Group Inc (PTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Mizuho Financial Group Inc:企業の戦略・SWOT・財務情報
    Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Mizuho Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • JSC IC Allianz:企業の戦略・SWOT・財務分析
    JSC IC Allianz - Strategy, SWOT and Corporate Finance Report Summary JSC IC Allianz - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Medicure Inc (MPH):企業の財務・戦略的SWOT分析
    Summary Medicure Inc (Medicure) is a pharmaceutical company that strives to research, develop and commercialize therapeutics for cardiovascular diseases. The company offers products such as Aggrastat, a glycoprotein GP IIb/IIIa receptor antagonist indicated for the treatment of acute coronary syndro …
  • Senior Lifestyle Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Senior Lifestyle Corp (Senior Lifestyle) is a healthcare service provider that provides healthcare and resident services. The company owns and operates several senior living apartments and retirement communities. It provides life enrichment programs such as cultural and social activities, tr …
  • 1-800-FLOWERS.COM, Inc. (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM, Inc. (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Petro Welt Technologies AG (O2C):企業の財務・戦略的SWOT分析
    Petro Welt Technologies AG (O2C) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Spark New Zealand Limited (formerly Telecom Corporation of New Zealand Limited):戦略・SWOT・企業財務分析
    Spark New Zealand Limited (formerly Telecom Corporation of New Zealand Limited) - Strategy, SWOT and Corporate Finance Report Summary Spark New Zealand Limited (formerly Telecom Corporation of New Zealand Limited) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company da …
  • Sumitomo Mitsui Financial Group Inc:企業の戦略・SWOT・財務情報
    Sumitomo Mitsui Financial Group Inc - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Financial Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • A. K. Capital Services Ltd (530499):企業の財務・戦略的SWOT分析
    A. K. Capital Services Ltd (530499) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Asklepios BioPharmaceutical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Asklepios Biopharmaceutical Inc (Asklepios Biopharmaceutical) is a drug development company that develops and markets novel protein and cellular based therapies. The company’s products include BNP-CHF, biostrophin, AskBio009, BNP-FVIII, BNP-RP, BNP-TLE, and BNP-OA. It also provides products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆